that interact with the amino-terminal AF1 domain of human PR (hPR). We report here the cloning and characterization of a novel transcription coregulator termed steroid receptor RNA activator (SRA). We provide functional and mechanistic evidence that SRA acts as an RNA transcript and exists in a ribonucleoprotein complex that contains the AF2 coactivator SRC-1.
Results

Characterization of SRA
In an attempt to find cofactors that interact with steroid hormone receptors, our laboratory used different functional domains of the hPR as baits in a yeast two-hybrid screening system. We previously reported the isolation and characterization of a protein , and chromosome 5 BAC clone 319C17 (AC005214), although no functions for these sequences were described.
Northern analysis of poly(A) ϩ -selected mRNA from difTo determine the expression patterns of the correferent human tissue culture cell lines. All of the cell sponding RNA, we performed Northern analysis using lines tested expressed the ‫58.0ف‬ kb doublet species, a cDNA probe corresponding to the core sequence of whereas the smaller ‫7.0ف‬ kb species was expressed at human SRA. Major transcripts of 0.7-0.85 kilobases (kb) significantly higher levels in the breast cancer cell lines in length and less abundant transcripts of 1.3-1.5 kb MCF7 and T-47D, compared to the other cell lines inveswere detected in a human multiple tissue Northern blot tigated ( Figure 1B ). This isoform-specific expression (Clontech) (Figure 1B) , indicating that the isolated cDNAs was conserved in mouse tissue (not shown). We conwere likely to be full length. In addition, SRA was excluded that multiple SRA isoforms are expressed quantipressed at different levels in the tissues examined; trantatively in a tissue-and cell type-specific manner. scripts were enriched in liver and skeletal muscle but expressed at a low level in brain. Interestingly, the ex-SRA Is a Steroid Receptor-Specific Coactivator pression of the two messages in the 0.7-0.85 kb doublet
To investigate the functional role of SRA, we subcloned appeared to be tissue specific in the multiple tissue the cDNAs into mammalian expression vectors and asblot. A cell line-specific expression of these isoforms sayed the effect of SRA on PR-dependent transactivation. HeLa cells were cotransfected with the CMV-hPR (represented by the doublet) was also observed in a domains of rat GR as fusion proteins with the activation domain of GAL4 ( Figure 3B , right panel). As expected, neither the amino-terminally truncated GR⌬AF1 nor the SRC-1. These results indicated that SRA mediates transcriptional activation of steroid receptors by a mecha-DNA-binding domain of rat GR (GR-DBD) responded to SRA to enhance luciferase reporter activity. As a control, nism involving the AF1 of the receptors. We next tested the possibility that intramolecular "crosstalk" between GR⌬AF1 enhanced reporter activity in the presence of the AF1 and AF2 of the receptor is mediated by SRA and SRC-1 but found that coexpression of both coactivators had only an additive effect on the coactivation of PRmediated transactivation (not shown). To better determine the coactivation potential of SRA in vivo, we transfected different SRA clones into T-47D cells and tested the ability of SRA to enhance the activity of endogenous PR. All three isoforms of SRA cDNA, in addition to a portion of the human genomic SRA, enhanced transactivation mediated by the endogenous PR by 8-to 12-fold, and the core domain of SRA was found to be necessary and sufficient for this coactivation (not shown).
Another criterion for classification as a coactivator is the ability of a factor to reverse interference (squelching) by transcriptional activators with common coregulators. To ask if SRA is a limiting factor that can be sequestered by an excess of another receptor, we used a PR-regulated gene reporter assay in the presence of ER ( Figure  3C ): while ligand-activated ER reduced the transcription activity of PR by 50%, full PR transactivation was reestablished by addition of SRA, confirming that SRA regulates the transactivation of both PR and ER in a dosedependent manner and indicating that SRA is a limiting cellular factor for steroid receptors.
In order to assess the effect of abrogation of endogenous SRA on PR-mediated transcription, we developed an assay in which SRA transcripts were selectively de- We next attempted to characterize the presumptive SRA protein product. Surprisingly, all our efforts to generate SRA-encoded protein were unsuccessful. In vitro translation of different SRA cDNAs did not result in detectable levels of protein, whereas carboxy-terminal fusions of SRA with GAL4 or GST produced the expected translation products (not shown). In addition, GAL/SRA fusion constructs failed to activate the UAS heterologous promoter, indicating that SRA did not possess an intrinsic activation function. We then generated a monoclonal antibody (mAb) against the peptide sequence encoded by the 3Ј end of the SRA core (ORF1). In Western analysis, only ORF1 fusion constructs of GAL/SRA and GST/SRA were immunoreactive (not shown), whereas no proteins generated by expressed SRA cDNAs were detectable in cell extracts. We concluded that the SRA cDNA sequence did not encode a viable translation product.
We then correlated the coactivation function of SRA We next focused our attention on the transcription prodTaken together, these results suggested to us that coucts of the cDNA encoding SRA. We designed an assay activation by SRA was unlikely to be mediated by its for RNA-mediated transactivation by targeting endogepresumptive protein product. nous GR in HeLa cells cultured in the presence of the In order to substantiate these results, we generated de novo protein synthesis inhibitor cycloheximide and various SRA mutants and tested them in cell culture for asked if SRA retained the ability to coactivate GR-meditheir ability to coactivate PR-dependent transcription. ated transcription. As controls, we used the coregulators Figure 4A RNase H, which destroyed the SRA signal in an oligonu-SRA was undetectable after immunoprecipitation using a nonspecific antibody from cell lysates programmed cleotide-and dose-dependent manner (not shown). We found that endogenous SRA specifically eluted in comwith SRA (lane 1). Similarly, SRA was not detected after immunoprecipitation with an AR antibody from cell lyplexes of 600-700 kDa ( Figure 6A, fractions 34 and 35) . We verified that these fractions do not reflect a nonspesates injected with RNA encoding AR, although AR was specifically precipitated (lane 2). In contrast, the AR anticific peak of proteins and RNA ( Figure 6A, upper panels) . Western analysis indicated that SRA copurified with body precipitated SRA in a hormone-independent manner in extracts from oocytes injected with RNAs for SRA fractions containing SRC-1 ( Figure 6A, SRC-1 Having established that SRA was present in SRC-1-a typical enhancement of receptor gene activity of ‫-01ف‬ fold was achieved by coexpression of SRA. Antisense containing complexes, we wished to know whether SRA interacted with steroid receptors as a component of a deoxyoligonucleotides added to cells reduced steroid receptor-induced transcription by up to 70%. In addiribonucleoprotein complex. To address this possibility, we performed coimmunoprecipitation experiments ustion, we have shown that SRA reverses steroid receptor squelching in a dose-dependent manner. Hence, SRA ing a previously described expression system in Xenopus oocytes (Wong et al., 1995) . In vitro-generated RNAs exhibits many characteristics expected of a bona fide coactivator. encoding SRA, SRC-1, p300, AR and the AR mutant AR⌬AF1, TR, RXR, and the nonnuclear receptor tranDespite certain functional similarities, SRA differs in some important aspects from many other coactivators scription factor Sp1, along with L-35 S-methionine, were injected into oocytes and their cell extracts subjected in that its coactivation is selective and that it is an RNA. We have presented several independent lines of evito coimmunoprecipitation with antibodies against the expected protein products. Figure 6C 
Gel Filtration
Biochemical fractionation of cell lysate on a Superose 6 gel filtration restricted SRA to the HSV-TK leader sequence generated tk-ORF1 and tk-ORF2, respectively. The reading frame mutations ORF1, column (Pharmacia) was carried out as described (McKenna et al., 1998) except that cell lysates contained 1-2 U/l RNasin ribo-ORF2, and ORF3 were generated by PCR using the sense primers 5Ј-TGGGGGATCCTACCTCAGGTGCGG-3Ј, 5Ј-TGGGAGATCTATCC nuclease inhibitor (Promega) and the columns were preequilibrated with RNasin. For antibody shift experiments, clarified lysates were TAGGGTGCGG-3Ј, and 5Ј-TGGGGGATCCTACCTAGGGTGCGG-3Ј, followed by restriction subcloning into pSCT-SRA. YIle used the preincubated at 4ЊC with 2 g of SRC-1 mAb and a 4-fold excess of rabbit anti-mouse IgG (Zymed). Half of each column fraction (400 primer 5Ј-ATAGCAATTGGGCCTCCACCTCCTTCAAG-3Ј to destroy an ATG and to introduce an MfeI site in mutant ORF2. Frameshift l) was processed for RNA isolation and RT-PCR analysis, while the other portion was precipitated with BSA/trichloracetic acid, sepmutations were generated by restriction of SRA or mutant ORF2 with selected enzymes, filled in with Klenow DNA polymerase, and arated on 7.5% polyacrylamide gels, and transferred overnight to nitrocellulose membrane (BioRad) at 0ЊC-4ЊC for Western analysis. re-ligated at the following sites: BbsI (generated mutant B), SgrAI (S), MfeI and SgrAI (MS, YMS), and MfeI, BbsI, and SgrAI (YMBS). 3Ј deletions at BbsI of ORF1, ORF2, and ORF3 generated ⌬ORF1, SRA-Specific RT-PCR ⌬ORF2, and ⌬ORF3. 
